Streetbeat News

Stock Prices

DPRO

Draganfly shares surged following the announcement of improved year-over-year Q1 EPS results.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 9:22 pm

DPRO

Draganfly reported a Q1 EPS of $(0.02), an improvement from $(0.15) YoY, but sales decreased to $986.46K from $1.19M YoY.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 9:22 pm

HLF

LFVN

OLPX

SKIN

Herbalife (NYSE:HLF) reported Q1 earnings, beating estimates with an EPS of $0.49 against the expected $0.34 and a revenue increase of $12.00 million year-over-year. The company's stock price rose 10.14% following the announcement. Competitors Olaplex Hldgs, Beauty Health, and Lifevantage also reported earnings, with varied performance and stock price reactions. Herbalife's earnings outperformance contrasts with its previous quarter's miss and subsequent share price drop.

Portfolio Pulse from Benzinga Insights

May 14, 2024 | 9:21 pm

PXLW

Pixelworks anticipates Q2 total revenue of $8M-$9M, significantly below the estimated $16.5M, with an adjusted EPS loss of $(0.16)-$(0.13), worse than the estimated $(0.07). The company attributes the shortfall to near-term headwinds in its mobile business but expects a return to sequential growth in H2. The anticipated non-GAAP gross profit margin is between 50% and 52%.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 9:18 pm

GENK

GEN Restaurant Group's shares surged following the announcement of their Q1 financial results, which exceeded market expectations.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 9:11 pm

ARQT

Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) reported Q1 earnings of 32 cents per share, surpassing the expected losses of 73 cents. Sales reached $49.57 million, exceeding estimates by 237.66% and marking a 1,680% increase from the previous year. The company highlighted strong sales from its ZORYVE franchise, with significant growth in both its cream and foam products for skin conditions. CEO Frank Watanabe emphasized the successful launch and physician adoption of ZORYVE, anticipating a transformative year ahead with a PDUFA date set for July 7th for ZORYVE cream as a potential atopic dermatitis treatment. Following the announcement, ARQT shares surged 15.01% in after-hours trading.

Portfolio Pulse from Erica Kollmann

May 14, 2024 | 9:11 pm

TNON

Tenon Medical shares are trading lower following the announcement of worse-than-expected Q1 sales results.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 9:11 pm

IRIX

IRIDEX shares are trading lower following the announcement of worse-than-expected Q1 financial results.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 9:10 pm

BOC

Boston Omaha reported Q1 earnings with a loss of $(0.09) per share, missing the $(0.04) estimate, but sales of $25.55M exceeded the $25.50M forecast. This represents an 18.18% improvement in losses and a 12% increase in sales year-over-year.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 9:09 pm

VOXX

VOXX International's shares dropped following the announcement of their Q4 financial results, which were below market expectations.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 9:08 pm